If that lawsuit becomes a national class action lawsuit, there is talk of $200 being paid to all persons using insulin. According to the ADA and the US govt there are over 25 million people in the US with T1 diabetes. That adds up to over 25 million dollars! Not to mention the people with type 2 requiring insulin. What about paying that money to research to research working to find a cure!?
25 million is something like 1/12 of the total population in the US… doesn’t sound right;). And 25 million times 200 equals 5 billion.
I’m a lot more interested in seeing it potentially bringing some change to the absolutely predatory drug pricing in this country than in collecting $200
2 Likes
The number is even bigger than 25 million, but it includes T1 and T2. And there are millions more who don’t have a dx yet. But yes, I’d also rather see some change in pricing for a lifesaving medication than getting a check that might buy me one little vial. YAY for whomever is filing this against the PBM’ and the makers. Calling it a win, or at least a move into the faster lane 
I think the number is 1.25 million have T1.
I just paid $650 for 2 boxes of Lantus pens. $200 is not going to do much for me. The Lantus Savings Card for 2017 will save me $640 - I’ll take that over the $200.
Now with no savings on Humalog in 2017, I’ll take the $200… The only less expensive option, but doesn’t count toward the deductible, is through www.blinkhealth.com. It’s $323 per box instead of the $487 I pay through my insurance. I’ll have to check prices for Apidra and Novalog with savings cards since I can’t use my insurance with blink anyway.
Yes, there are just over 1 million T1Ds, though they don’t really have a true accurate count because it’s not a reportable condition.
I wonder what took so long for a lawsuit? Seems pretty clear they are ripping us off when all insulins in London, and every other international city/country I’ve traveled, can be bought over the counter (with local Rx) for less than $50.
Shadpw2 - you are right. I made a major typo. The number of people dx with T1 per the ADA in 2012 is 1.25 million. The math I did was thus in error (should used a calculator - but I was preparing the family dinner at the same time). So the cost to the mfr’s if they lose the class action suit - and we toss in the T2’s - cuz there are a lot of them who require insullin - and many who have a really hard time affording it (like a lot of us) I still think the $ would do more good with the NIH doing research, And it is ironic - which I love 0 I like irony - that the research could end up ending the era of my life as a cash cow
Thanks for pointing out my error - I wanted it to be correct
1 Like
From the ADA - Today: Statistics About Diabetes Overall Numbers, Diabetes and Prediabetes Prevalence the number of people in a given group or population who are reported to have a disease.
In 2012, 29.1 million Americans, or 9.3% of the population, had diabetes. Approximately 1.25 million American children and adults have type 1 diabetes. Undiagnosed: Of the 29.1 million, 21.0 million were diagnosed, and 8.1 million were undiagnosed.
Diabetes remains the 7th leading cause of death in the United States in 2010, with 69,071 death certificates listing it as the underlying cause of death, and a total of 234,051 death certificates listing diabetes as an underlying or contributing cause of death. Diabetes in Youth About 208,000 Americans under age 20 are estimated to have diagnosed diabetes, approximately 0.25% of that population. In 2008—2009, the annual incidence a measure of how often a disease occurs; the number of new cases of a disease among a certain group of people for a certain period of time.
The numbers are increasing, THAT is a fact. And insulin should not be out of reach for any type of diabetic.
Take a second look at sulfa drugs. They work for type 2 and are cheap.
Insulin prices in the U.S. are criminal.
Tobacco took a $20 billion hit and survived just fine. Pharma could absorb $5 billion without breathing hard. As others have said, $200 wouldn’t make a difference for me. I’d rather see a real systemic result.